IN THIS ISSUE/RESEARCH WATCH/NEWS-IN-BRIEF/NEWS FROM THE IASLC TOBACCO CONTROL COMMITTEE
Lung Cancer in Pregnancy—A Forgotten Disease Entity
Selective Application of Lobe-Specific Node Dissection
MET in the Driver's Seat: Exon 14 Skipping Mutations as Actionable Targets in Lung Cancer
Residential Radon: The Neglected Risk Factor in Lung Cancer Risk Scores
Clinician Perspectives on Current Issues in Lung Cancer Drug Development
The Utility of Exercise Testing in Patients with Lung Cancer
Clinicopathologic Features of Advanced Squamous NSCLC
cMET Exon 14 Skipping: From the Structure to the Clinic
The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer
Patients with a Previous History of Malignancy Undergoing Lung Cancer Screening: Clinical Characteristics and Radiologic Findings
Long-Term Follow-up of Small Pulmonary Ground-Glass Nodules Stable for 3 Years: Implications of the Proper Follow-up Period and Risk Factors for Subsequent Growth
Does a Multimodal No-Compression Suture Technique of the Intercostal Space Reduce Chronic Postthoracotomy Pain? A Prospective Randomized Study
ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations
The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC
Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping
Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis
Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes
Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls
Isolated Nodal Failure after Stereotactic Body Radiotherapy for Lung Cancer: The Role for Salvage Mediastinal Radiotherapy
A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non–Small Cell Lung Cancer
Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Phase III Randomized Controlled Trials Evaluating the First-Line Chemotherapy for Advanced, Locally Advanced, and Recurrent Non–Small Cell Lung Carcinoma
Characteristics of Smoking Patients with Lung Cancer with Emphysematous Bullae
An Unusual Cause of Dysphagia with Bronchoesophageal Fistula
Erratum
A Novel EGFRC797 Variant Detected in a Pleural Biopsy Specimen from an Osimertinib-Treated Patient Using a Comprehensive Hybrid Capture–Based Next-Generation Sequencing Assay
Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF -Mutated Lung Adenocarcinoma
Which Epidemiological Factors Have the Most Influence on the EGFR Mutation Frequency in Lung Adenocarcinoma?
In Reply to the Letter to the Editor Titled “Which Epidemiological Factors Have the Most Influence on the EGFR Mutation Frequency in Lung Adenocarcinoma?”